BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 26, 1998
View Archived Issues
New Na+/H+ exchange inhibitors in development at HMR
Read More
Nonsteroid progesterone antagonists for cancer, gynecological disorders
Read More
Beta-glucuronidase inhibitors as antitumor/antiinflammatory agents
Read More
FDA grants fast track status to Surfaxin in MAS
Read More
Benzamides with antiulcer, antisecretory and anti-H. pylori effects discovered at Shiseido
Read More
Safe and effective therapeutics for neuropathic pain in early development at Roche
Read More
In vitro studies point to potent, long-lasting antiplatelet effects for XV-459/DMP-754
Read More
Animal studies provide further support for the role of dopaminergic systems in alcoholism
Read More
Naamidine A identified as EGF receptor antagonist and antiproliferative agent
Read More
Sankyo designs new carbapenems with increased activity, stability to DHP-I
Read More
Antibacterial activity of hongoquercin A, a compound of fungal origin
Read More
Glycolipid derivative shows cardioprotective activity in animal models
Read More
First high-affinity, nonpeptide BB1, BB2 receptor antagonists designed at Parke-Davis
Read More
Camptosar receives final FDA approval for colorectal cancer
Read More
U.S. patent issues for Regeneron's Ang2 protein
Read More
Thalidomide designated orphan drug for multiple myeloma
Read More
Clinical trials of Combidex near completion, NDA filing scheduled for next year
Read More
Metabasis Therapeutics seeks partner for development of anticonvulsant
Read More
Endorex/Elan joint venture to develop Medipad-based drugs
Read More
Positive phase II results obtained for Allelix's recombinant hPTH in osteoporosis
Read More
Anti-HIV drug candidate DMP-851 reviewed in the literature
Read More
Muse effective in patients with ED resulting from radical prostatectomy
Read More
New study compares balsalazide to mesalamine
Read More
Transdermal D2 agonist therapy with N-0923 safe and effective in PD
Read More
STAR study will compare raloxifene to tamoxifen for reducing risk of breast cancer
Read More
Transdermal selegiline as monotherapy in mild to moderate Parkinson's disease
Read More
Phase I studies establish feasibility, tolerability of oral delivery of heparin
Read More
Sublingual apomorphine safe and effective in PD patients with motor fluctuations
Read More
